HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Clendenning Selected Research

Neoplasms (Cancer)

10/2023A mosaic pathogenic variant in MSH6 causes MSH6-deficient colorectal and endometrial cancer in a patient classified as suspected Lynch syndrome: a case report.
3/2023Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival.
3/2023A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome.
2/2023Evaluating Multiple Next-Generation Sequencing-Derived Tumor Features to Accurately Predict DNA Mismatch Repair Status.
1/2023A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome.
1/2020Mismatch repair gene pathogenic germline variants in a population-based cohort of breast cancer.
1/2018RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.
1/2018Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype.
11/2017Targeted sequencing of established and candidate colorectal cancer genes in the Colon Cancer Family Registry Cohort.
9/2017Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Clendenning Research Topics

Disease

34Neoplasms (Cancer)
10/2023 - 05/2006
29Colorectal Neoplasms (Colorectal Cancer)
01/2024 - 02/2008
15Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
01/2020 - 08/2008
12Microsatellite Instability
03/2023 - 02/2007
6Colonic Neoplasms (Colon Cancer)
01/2021 - 05/2012
5Endometrial Neoplasms (Endometrial Cancer)
02/2023 - 07/2013
5Turcot syndrome
01/2019 - 01/2009
3Breast Neoplasms (Breast Cancer)
01/2020 - 04/2010
3Adenoma (Adenomas)
01/2018 - 07/2010
3Polyps
06/2012 - 07/2010
1Diabetes Mellitus
11/2019
1Type 2 Diabetes Mellitus (MODY)
11/2019
1Prostatic Neoplasms (Prostate Cancer)
12/2014
1Necrosis
04/2010
1Intellectual Disability (Idiocy)
02/2008
1Agammaglobulinemia (Hypogammaglobulinemia)
02/2008
1Astrocytoma (Pilocytic Astrocytoma)
02/2008

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
01/2019 - 02/2007
14DNA (Deoxyribonucleic Acid)IBA
01/2024 - 07/2013
8Calcibiotic Root Canal SealerIBA
12/2023 - 01/2009
4A-Form DNA (A-DNA)IBA
01/2016 - 08/2011
3Epithelial Cell Adhesion MoleculeIBA
01/2021 - 11/2015
3Biomarkers (Surrogate Marker)IBA
01/2017 - 03/2015
3Mismatch Repair Endonuclease PMS2IBA
09/2013 - 05/2006
2Codon (Codons)IBA
01/2018 - 06/2013
2Ethanol (Ethyl Alcohol)IBA
01/2017 - 01/2017
2CalciumIBA
01/2016 - 03/2015
2Hormones (Hormone)IBA
07/2015 - 04/2010
2MucinsIBA
12/2013 - 07/2013
1MutagensIBA
03/2023
1colibactinIBA
03/2023
1CholesterolIBA
11/2019
1Triglycerides (Triacylglycerol)IBA
11/2019
1Exonucleases (3' 5' Exonuclease)IBA
01/2018
1NucleotidesIBA
11/2017
1MicroRNAs (MicroRNA)IBA
01/2017
1O-(6)-methylguanineIBA
12/2016
1MethyltransferasesIBA
12/2016
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2016
1Ibuprofen (Motrin)FDA LinkGeneric
09/2015
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
09/2015
1Contraceptive Agents (Contraceptives)IBA
07/2015
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
03/2015
1RNA Splice SitesIBA
06/2011
1SmokeIBA
07/2010
1SteroidsIBA
04/2010
1Progesterone Receptors (Progesterone Receptor)IBA
04/2010
1Estrogen ReceptorsIBA
04/2010
1EpitopesIBA
01/2009
1Coloring Agents (Dyes)IBA
01/2009
1Transcobalamins (Transcobalamin II)IBA
02/2008

Therapy/Procedure

3Ligation
02/2017 - 08/2008
2Precision Medicine
02/2023 - 01/2020
1Drug Therapy (Chemotherapy)
01/2017
1Hysterectomy
07/2015